Intracranial efficacy of crizotinib versus chemotherapy in patients with advanced ALK-positive non-small-cell lung cancer: results from PROFILE 1014.
Solomon, B Cappuzzo, F Felip, E Costa, D Kim, D Nakagawa, K Wu, Y Mekhail, T Paolini, J
Solomon, B
Cappuzzo, F
Felip, E
Costa, D
Kim, D
Nakagawa, K
Wu, Y
Mekhail, T
Paolini, J
Citations
Altmetric:
Abstract
Intracranial efficacy of first-line crizotinib versus chemotherapy was compared prospectively in the phase III PROFILE 1014 study in ALK-positive non-small-cell lung cancer.
Description
Date
2016-03-28
Publisher
Collections
Keywords
Type
Article
Citation
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014. 2016: J Clin Oncol